Prostate cancer is one of the most common cancers in men. On-going research programs are searching for better ways of diagnosing and treating this serious disease. Prostate cancer is the second most common cancer in men. Prostate cancer can be treated if caught early enough, however, there are few effective treatments for advanced prostate cancer.
Current options to treat cancer include surgery, chemotherapy, and radiotherapy; but will there ever be a cancer vaccine? Vaccines are a powerful method to prevent infectious diseases. They work by stimulating the immune system to mount a reaction against dangerous germs. The success of vaccines in controlling infectious diseases prompted scientists to explore their use
Reading Time: 2 minutes In a recent study, researchers examine breast cancer recurrence by the creation of two tumor models. There are a certain group of breast cancer patients who are described to have oestrogen receptor (ER) alpha-positive (ER+) tumors . These tumors are especially resistant to adjuvant oestrogen deprivation therapy because those with
A new study published in PLOS Medicine investigated how obesity contributes to the development of kidney cancer. Multiple studies have demonstrated a consistent positive association between obesity and kidney cancer, regardless of risk factors for this cancer such as hypertension. This relationship have been found to be stronger in women, although it has also been
A recent study analyzing the receptor that leads to nausea could be crucial in the development of drugs to reduce chemotherapy side effects. Most currently used cancer drugs are known to cause many chemotherapy side effects. These unpleasant side effects are sensed through a class of receptors called neurokin 1 receptor (NK1R). Pharmacological targeting of these
A new study published in Nature Medicine has shown a way to decode the fate of precancerous lung lesions in the development of invasive lung cancer. Lung cancer is the deadliest form of cancer worldwide, causing an estimated 1.8 million deaths globally in 2018. The disease develops when abnormal cancer cells in the lungs begin